Kenya’s healthcare market is recognized as one of Africa’s top systems, ranking just behind South Africa in access and quality.
At the launch of the “State of Kenya’s Health Market 2024” report, stakeholders noted that while advancements have been made, significant challenges persist.
Lyndon Marani, a technical adviser for the USAID Private Sector Engagement Programme, highlighted both achievements and ongoing issues. He stated, “The Kenyan healthcare market has made great strides. However, critical cash flow challenges threaten these gains.”
He explained that delays in payments to the National Hospital Insurance Fund (NHIF) create a ripple effect throughout the healthcare supply chain. “When NHIF payments are delayed, hospitals aren’t compensated on time, which in turn delays payments to drug distributors. This cycle ultimately impacts patient care and the system’s overall effectiveness,” he added.
The report emphasizes the crucial roles of both public and private sectors in healthcare, noting that universal health coverage remains a government priority. However, gaps in financing remain, with many counties overly reliant on national funding and donor support.
Marani pointed out that only 50% of locally manufactured health products and technologies are utilized, highlighting underutilization in Kenya’s pharmaceutical manufacturing sector. Although Kenyan drugs are highly regarded across East Africa, there remains a strong preference for imported medications.
“We are only using half of our drug manufacturing capacity, leaving the rest idle,” he noted. This reliance on imports also extends to medical fluids, much of which comes from abroad. “It’s surprising, given that local companies can meet our needs,” he remarked.
On health information management, Marani noted that valuable data exists within both sectors but isn’t effectively utilized for timely decision-making, hampering the government’s response to public health emergencies.
Margaret Njenga, CEO of Population Services Kenya, echoed Marani’s concerns, particularly regarding financing and service delivery. She highlighted the decline in healthcare services at the community level and the urgent need for a coordinated approach.
“While we have made progress, we have yet to meet the Abuja Declaration’s recommendation of allocating 15% of the national budget to health,” Njenga said, noting that Kenya currently allocates about 11%, which is insufficient.
She emphasized the importance of viewing healthcare as a vital market that includes both public and private sectors, noting that small private clinics provide up to 50% of healthcare services, yet remain underfunded.
Both Njenga and Marani called for better coordination among manufacturers, the Ministry of Health, pharmacies, and healthcare facilities.
Marani stressed that as Kenya addresses these challenges, stakeholders must recognize healthcare’s interconnectedness with economic development. By fostering collaboration and viewing healthcare as an economic driver, Kenya can enhance patient outcomes and solidify its position as a regional healthcare leader.
Njenga added that a dual investment strategy prioritizing both public and private healthcare sectors could significantly improve access and quality for all Kenyans.
